550
Participants
Start Date
September 5, 2017
Primary Completion Date
August 31, 2028
Study Completion Date
December 31, 2032
Molecular profiling and drug testing
"1. Laboratory analysis including:~ A. Tumour molecular profiling: targeted whole exon variant analysis, whole genome (DNA) and transcriptome (RNA) sequencing, methylation analysis, proteomics analysis, immunohistochemistry B. In vitro high-throughput drug sensitivity testing C. In vivo drug testing using patient-derived xenograft (PDX) models D. Liquid biopsies~2. Multi-disciplinary Tumour Board case discussion~3. Recommendation of personalised therapy"
Sydney Children's Hospital, Randwick, Sydney
The Children's Hospital at Westmead, Sydney
John Hunter Children's Hospital, Newcastle
Royal Children's Hospital, Melbourne
Monash Children's Hospital, Melbourne
Queensland Children's Hospital, Brisbane
Women's and Children's Hospital, Adelaide
Perth Children's Hospital, Perth
Collaborators (1)
Children's Cancer Institute Australia
UNKNOWN
Australian & New Zealand Children's Haematology/Oncology Group
OTHER
Garvan Institute of Medical Research
OTHER
German Cancer Research Center
OTHER
Sydney Children's Hospitals Network
OTHER